The Circadian Gene NPAS2 Act as a Putative Tumor Stimulative Factor for Uterine Corpus Endometrial Carcinoma

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30. doi:10.3322/caac.2138728055103
   PubMed Web of Science ®Google Scholar
• Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983;15(1):10–17. doi:10.1016/0090-8258(83)90111-76822361
   PubMed Web of Science ®Google Scholar
• Bansal N, Yendluri V, Wenham RM. The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies. Cancer Control. 2009;16(1):8–13. doi:10.1177/10732748090160010219078924
   PubMed Web of Science ®Google Scholar
• Greene MW. Circadian rhythms and tumor growth. Cancer Lett. 2012;318(2):115–123. doi:10.1016/j.canlet.2012.01.00122252116
   PubMed Web of Science ®Google Scholar
• Baker FC, Driver HS. Circadian rhythms, sleep, and the menstrual cycle. Sleep Med. 2007;8(6):613–622. doi:10.1016/j.sleep.2006.09.01117383933
   PubMed Web of Science ®Google Scholar
• Reick M, Garcia JA, Dudley C, McKnight SL. NPAS2: an analog of clock operative in the mammalian forebrain. Science. 2001;293(5529):506–509. doi:10.1126/science.106069911441147
   PubMed Web of Science ®Google Scholar
• Dioum EM, Rutter J, Tuckerman JR, Gonzalez G, Gilles-Gonzalez MA, McKnight SL. NPAS2: a gas-responsive transcription factor. Science. 2002;298(5602):2385–2387. doi:10.1126/science.107845612446832
   PubMed Web of Science ®Google Scholar
• Hoffman AE, Zheng T, Ba Y, Zhu Y. The circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage response. Mol Cancer Res. 2008;6(9):1461–1468. doi:10.1158/1541-7786.MCR-07-209418819933
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–w102.28407145
   PubMed Web of Science ®Google Scholar
• Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649–658. doi:10.1016/j.neo.2017.05.00228732212
   PubMed Web of Science ®Google Scholar
• Lánczky A, Győrffy B. Web-based survival analysis tool tailored for medical research (KMplot): development and implementation. J Med Internet Res. 2021;23(7):e27633. doi:10.2196/2763334309564
   PubMed Web of Science ®Google Scholar
• Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1. doi:10.1126/scisignal.200408823550210
   PubMed Web of Science ®Google Scholar
• Li T, Fan J, Wang B, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77(21):e108–e110. doi:10.1158/0008-5472.CAN-17-030729092952
   PubMed Web of Science ®Google Scholar
• Vasaikar SV, Straub P, Wang J, Zhang B. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 2018;46(D1):D956–d963. doi:10.1093/nar/gkx109029136207
   PubMed Web of Science ®Google Scholar
• Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(D1):D92–97. doi:10.1093/nar/gkt124824297251
   PubMed Web of Science ®Google Scholar
• Zheng X, Xu K, Zhu L, Mao M, Zhang F, Cui L. MiR-486-5p act as a biomarker in endometrial carcinoma: promotes cell proliferation, migration, invasion by targeting MARK1. Onco Targets Ther. 2020;13:4843–4853. doi:10.2147/OTT.S24684132547110
   PubMed Web of Science ®Google Scholar
• De A, Beligala DH, Sharma VP, Burgos CA, Lee AM, Geusz ME. Cancer stem cell generation during epithelial-mesenchymal transition is temporally gated by intrinsic circadian clocks. Clin Exp Metastasis. 2020;37(5):617–635. doi:10.1007/s10585-020-10051-132816185
   PubMed Web of Science ®Google Scholar
• Markowska A, Pawałowska M, Lubin J, Markowska J. Signalling pathways in endometrial cancer. Contemp Oncol. 2014;18(3):143–148. doi:10.5114/wo.2014.43154
   Google Scholar
• Lin AB, McNeely SC, Beckmann RP. Achieving precision death with cell-cycle Inhibitors that target DNA replication and repair. Clin Cancer Res. 2017;23(13):3232–3240. doi:10.1158/1078-0432.CCR-16-008328331049
   PubMed Web of Science ®Google Scholar
• Kelleher FC, Rao A, Maguire A. Circadian molecular clocks and cancer. Cancer Lett. 2014;342(1):9–18. doi:10.1016/j.canlet.2013.09.04024099911
   PubMed Web of Science ®Google Scholar
• Reszka E, Przybek M, Muurlink O, Pepłonska B. Circadian gene variants and breast cancer. Cancer Lett. 2017;390:137–145. doi:10.1016/j.canlet.2017.01.01228109907
   PubMed Web of Science ®Google Scholar
• Yi C, Mu L, de la Longrais IA, et al. The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer. Breast Cancer Res Treat. 2010;120(3):663–669. doi:10.1007/s10549-009-0484-019649706
   PubMed Web of Science ®Google Scholar
• Xue X, Liu F, Han Y, et al. Silencing NPAS2 promotes cell growth and invasion in DLD-1 cells and correlated with poor prognosis of colorectal cancer. Biochem Biophys Res Commun. 2014;450(2):1058–1062. doi:10.1016/j.bbrc.2014.06.10424978311
   PubMed Web of Science ®Google Scholar
• Yuan P, Yang T, Mu J, et al. Circadian clock gene NPAS2 promotes reprogramming of glucose metabolism in hepatocellular carcinoma cells. Cancer Lett. 2020;469:498–509. doi:10.1016/j.canlet.2019.11.02431765736
   PubMed Web of Science ®Google Scholar
• Song B, Chen Y, Liu Y, Wan C, Zhang L, Zhang W. NPAS2 regulates proliferation of acute myeloid leukemia cells via CDC25A-mediated cell cycle progression and apoptosis. J Cell Biochem. 2018. doi:10.1002/jcb.28160
   Web of Science ®Google Scholar
• Zhu Y, Leaderer D, Guss C, et al. Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin’s lymphoma. Int J Cancer. 2007;120(2):432–435. doi:10.1002/ijc.2232117096334
   PubMed Web of Science ®Google Scholar
• Zhao F, Pu Y, Qian L, Zang C, Tao Z, Gao J. MiR-20a-5p promotes radio-resistance by targeting NPAS2 in nasopharyngeal cancer cells. Oncotarget. 2017;8(62):105873–105881. doi:10.18632/oncotarget.2241129285299
   PubMedGoogle Scholar
• Yuan P, Li J, Zhou F, et al. NPAS2 promotes cell survival of hepatocellular carcinoma by transactivating CDC25A. Cell Death Dis. 2017;8(3):e2704. doi:10.1038/cddis.2017.13128333141
   PubMed Web of Science ®Google Scholar
• Esquifino AI, Selgas L, Arce A, Maggiore VD, Cardinali DP. Twenty-four-hour rhythms in immune responses in rat submaxillary lymph nodes and spleen: effect of cyclosporine. Brain Behav Immun. 1996;10(2):92–102. doi:10.1006/brbi.1996.00108811933
   PubMed Web of Science ®Google Scholar
• Arjona A, Sarkar DK. Circadian oscillations of clock genes, cytolytic factors, and cytokines in rat NK cells. J Immunol. 2005;174(12):7618–7624. doi:10.4049/jimmunol.174.12.761815944262
   PubMed Web of Science ®Google Scholar
• Gamaleia NF, Skivka LM, Fedorchuk AG, Shishko ED. Circadian rhythms of cytotoxic activity in peripheral blood mononuclear cells of patients with malignant melanoma. Exp Oncol. 2006;28(1):54–60.16614709
   PubMedGoogle Scholar
• Zhao W, Geng P, Li Y, Wei X, Cheng J. MicroRNA-21 promotes endometrial carcinoma proliferation and invasion by targeting PTEN. Int J Clin Exp Pathol. 2017;10(12):11489–11495.31966504
   PubMed Web of Science ®Google Scholar
• Shen Y, Lu L, Xu J, et al. Bortezomib induces apoptosis of endometrial cancer cells through microRNA-17-5p by targeting p21. Cell Biol Int. 2013;37(10):1114–1121. doi:10.1002/cbin.1013923716467
   PubMed Web of Science ®Google Scholar
• Zhang K, Cai Y, Zhou Q, Sun H, Wei J. Long non-coding RNA SNHG14 impedes viability, migration and invasion of endometrial carcinoma cells through modulating miR-93-5p/ZBTB7A axis. Cancer Manag Res. 2020;12:9515–9525. doi:10.2147/CMAR.S25741933061638
   PubMed Web of Science ®Google Scholar